Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$17.56 - $23.76 $163,308 - $220,968
9,300 New
9,300 $215,000
Q1 2020

May 15, 2020

SELL
$9.78 - $29.53 $391,200 - $1.18 Million
-40,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$20.93 - $35.1 $460,460 - $772,200
-22,000 Reduced 35.48%
40,000 $1.09 Million
Q3 2019

Nov 14, 2019

BUY
$22.08 - $47.08 $1.37 Million - $2.92 Million
62,000 New
62,000 $1.78 Million
Q2 2019

Aug 13, 2019

SELL
$22.67 - $35.0 $2.27 Million - $3.5 Million
-100,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$26.93 - $34.7 $2.69 Million - $3.47 Million
100,000 New
100,000 $3.32 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.08B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.